SpringTide Ventures

SpringTide Ventures is an influential early-stage venture capital firm based in Cambridge, Massachusetts, specializing in HealthTech investments. With a strategic focus on digital health, medical devices, life sciences, and tech-enabled care delivery, the firm recently closed its second fund at $65 million, bringing its total assets under management to over $100 million. SpringTide Ventures has a history of backing groundbreaking companies like GreatExpectations.io, a leader in data quality tooling; Pathology Watch, an AI-powered dermatopathology platform; Debut Biotech, a pioneer in cell-free biomanufacturing; and OpenLoop, an end-to-end telemedicine enablement company. These investments highlight SpringTide's commitment to leveraging advanced technologies to enhance patient care and improve health outcomes. Founded by Austin Walters, the firm emphasizes a hands-on approach, working closely with its portfolio companies to navigate growth stages and achieve significant market impact. SpringTide Ventures invests primarily in seed and Series A rounds, focusing on startups that address critical healthcare needs with innovative solutions.